MedWatch

Novo Nordisk postpones launch of intelligent insulin pens

Novo Nordisk was supposed to launch two intelligent insulin pens in the US and EU this year. Now, the Danish drug group calls in the products, which means that a broader launch will not happen before 2020 - one year later than planned.

Foto: Novo Nordisk/PR

In October 2018, Novo Nordisk announced that the launch of two intelligent durable insulin pens would begin in 2019. Until then, the pens had been pilot tested on the Swedish market. However, the Danish drug group now postpones the global launch of the products to the beginning of 2020 earliest.

Last week, the Swedish unit of Novo Nordisk announced the recall of thousands of products, including the brands Novopen 6, the child-friendly Novopen Echo Plus and Novopen 5 Plus, the name of Novopen 6 during the pilot project.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier